Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
life sciences
national blog main
national top stories
roche
4
×
boston
boston blog main
boston top stories
europe top stories
genentech
san francisco top stories
avapritinib
blueprint medicines
clinical trials
deals
eli lilly
europe blog main
fda
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
san francisco blog main
selpercatinib
thyroid cancer
billy dunn
biogen
biopharma
cancer
cancer drugs
capmatinib
cstone pharmaceuticals
drug prices
drug pricing
duchenne
european medicines agency
evrysdi
fisogatinib
flatiron health
gastrointestinal stromal tumors
What
fda
4
×
approval
drug
roche
therapy
blueprint
cancer
medicine
medicines
ret
address
approved
approves
atrophy
betting
billion
biopharma
candidate
carries
certain
currently
daily
deal
designed
duchenne
evrysdi
friday
gene
genetic
green
historic
home
intended
latest
lights
liquid
marketing
muscle
muscular
new
Language
unset
4
×
Current search:
roche
×
fda
×
biotech
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal